Pharmacy Articles

Pharmacy

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bramlage P - The evidence indicates that angiotensin converting enzyme inhibitor (ACEi)/CCB combinations are more effective in selected high-risk patients with compelling indications for the use of CCBs than are ACEi/HCTZ combinations. Side effects offset these data, and compelling indications may have favored the outcomes. Comparisons in a more unselected patient population are needed to define the role of particular drug–drug combinations.


Today in Dosing...keeping you current

Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09

Telavancin: A Novel Lipoglycopeptide
Clinical Infectious Diseases, 11/16/09

Risperidone dose for schizophrenia
Cochrane Reviews, 10/21/09